The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Intelligence Pathology Diagnosis Market Research Report 2025
Synopsis
The global Artificial Intelligence Pathology Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Pathology Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Pathology Diagnosis.
Report Scope
The Artificial Intelligence Pathology Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence Pathology Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence Pathology Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aiforia
AIRA Matrix
Deep Bio
DoMore Diagnostics
Indica Labs
Mindpeak
Paige AI
Path AI
Tempus
Verily
Aignostics GmbH
Gestalt Diagnostics
Primma
Segment by Type
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology
Segment by Application
Hospital
Diagnostic Laboratory
Training and Education
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence Pathology Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Artificial Intelligence Pathology Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Pathology Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Pathology Diagnosis.
Report Scope
The Artificial Intelligence Pathology Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence Pathology Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence Pathology Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aiforia
AIRA Matrix
Deep Bio
DoMore Diagnostics
Indica Labs
Mindpeak
Paige AI
Path AI
Tempus
Verily
Aignostics GmbH
Gestalt Diagnostics
Primma
Segment by Type
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology
Segment by Application
Hospital
Diagnostic Laboratory
Training and Education
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence Pathology Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Pathology Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Histopathology
1.2.3 Cytopathology
1.2.4 Immunohistochemical Pathology
1.2.5 Molecular Pathology
1.3 Market by Application
1.3.1 Global Artificial Intelligence Pathology Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic Laboratory
1.3.4 Training and Education
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Pathology Diagnosis Market Perspective (2019-2030)
2.2 Artificial Intelligence Pathology Diagnosis Growth Trends by Region
2.2.1 Global Artificial Intelligence Pathology Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence Pathology Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence Pathology Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence Pathology Diagnosis Market Dynamics
2.3.1 Artificial Intelligence Pathology Diagnosis Industry Trends
2.3.2 Artificial Intelligence Pathology Diagnosis Market Drivers
2.3.3 Artificial Intelligence Pathology Diagnosis Market Challenges
2.3.4 Artificial Intelligence Pathology Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Pathology Diagnosis Players by Revenue
3.1.1 Global Top Artificial Intelligence Pathology Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence Pathology Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Pathology Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence Pathology Diagnosis Revenue
3.4 Global Artificial Intelligence Pathology Diagnosis Market Concentration Ratio
3.4.1 Global Artificial Intelligence Pathology Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Pathology Diagnosis Revenue in 2023
3.5 Artificial Intelligence Pathology Diagnosis Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence Pathology Diagnosis Product Solution and Service
3.7 Date of Enter into Artificial Intelligence Pathology Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Pathology Diagnosis Breakdown Data by Type
4.1 Global Artificial Intelligence Pathology Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence Pathology Diagnosis Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence Pathology Diagnosis Breakdown Data by Application
5.1 Global Artificial Intelligence Pathology Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence Pathology Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence Pathology Diagnosis Market Size (2019-2030)
6.2 North America Artificial Intelligence Pathology Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence Pathology Diagnosis Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence Pathology Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence Pathology Diagnosis Market Size (2019-2030)
7.2 Europe Artificial Intelligence Pathology Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence Pathology Diagnosis Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence Pathology Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence Pathology Diagnosis Market Size (2019-2030)
9.2 Latin America Artificial Intelligence Pathology Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence Pathology Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence Pathology Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aiforia
11.1.1 Aiforia Company Detail
11.1.2 Aiforia Business Overview
11.1.3 Aiforia Artificial Intelligence Pathology Diagnosis Introduction
11.1.4 Aiforia Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.1.5 Aiforia Recent Development
11.2 AIRA Matrix
11.2.1 AIRA Matrix Company Detail
11.2.2 AIRA Matrix Business Overview
11.2.3 AIRA Matrix Artificial Intelligence Pathology Diagnosis Introduction
11.2.4 AIRA Matrix Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.2.5 AIRA Matrix Recent Development
11.3 Deep Bio
11.3.1 Deep Bio Company Detail
11.3.2 Deep Bio Business Overview
11.3.3 Deep Bio Artificial Intelligence Pathology Diagnosis Introduction
11.3.4 Deep Bio Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.3.5 Deep Bio Recent Development
11.4 DoMore Diagnostics
11.4.1 DoMore Diagnostics Company Detail
11.4.2 DoMore Diagnostics Business Overview
11.4.3 DoMore Diagnostics Artificial Intelligence Pathology Diagnosis Introduction
11.4.4 DoMore Diagnostics Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.4.5 DoMore Diagnostics Recent Development
11.5 Indica Labs
11.5.1 Indica Labs Company Detail
11.5.2 Indica Labs Business Overview
11.5.3 Indica Labs Artificial Intelligence Pathology Diagnosis Introduction
11.5.4 Indica Labs Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.5.5 Indica Labs Recent Development
11.6 Mindpeak
11.6.1 Mindpeak Company Detail
11.6.2 Mindpeak Business Overview
11.6.3 Mindpeak Artificial Intelligence Pathology Diagnosis Introduction
11.6.4 Mindpeak Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.6.5 Mindpeak Recent Development
11.7 Paige AI
11.7.1 Paige AI Company Detail
11.7.2 Paige AI Business Overview
11.7.3 Paige AI Artificial Intelligence Pathology Diagnosis Introduction
11.7.4 Paige AI Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.7.5 Paige AI Recent Development
11.8 Path AI
11.8.1 Path AI Company Detail
11.8.2 Path AI Business Overview
11.8.3 Path AI Artificial Intelligence Pathology Diagnosis Introduction
11.8.4 Path AI Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.8.5 Path AI Recent Development
11.9 Tempus
11.9.1 Tempus Company Detail
11.9.2 Tempus Business Overview
11.9.3 Tempus Artificial Intelligence Pathology Diagnosis Introduction
11.9.4 Tempus Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.9.5 Tempus Recent Development
11.10 Verily
11.10.1 Verily Company Detail
11.10.2 Verily Business Overview
11.10.3 Verily Artificial Intelligence Pathology Diagnosis Introduction
11.10.4 Verily Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.10.5 Verily Recent Development
11.11 Aignostics GmbH
11.11.1 Aignostics GmbH Company Detail
11.11.2 Aignostics GmbH Business Overview
11.11.3 Aignostics GmbH Artificial Intelligence Pathology Diagnosis Introduction
11.11.4 Aignostics GmbH Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.11.5 Aignostics GmbH Recent Development
11.12 Gestalt Diagnostics
11.12.1 Gestalt Diagnostics Company Detail
11.12.2 Gestalt Diagnostics Business Overview
11.12.3 Gestalt Diagnostics Artificial Intelligence Pathology Diagnosis Introduction
11.12.4 Gestalt Diagnostics Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.12.5 Gestalt Diagnostics Recent Development
11.13 Primma
11.13.1 Primma Company Detail
11.13.2 Primma Business Overview
11.13.3 Primma Artificial Intelligence Pathology Diagnosis Introduction
11.13.4 Primma Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
11.13.5 Primma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Artificial Intelligence Pathology Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Histopathology
Table 3. Key Players of Cytopathology
Table 4. Key Players of Immunohistochemical Pathology
Table 5. Key Players of Molecular Pathology
Table 6. Global Artificial Intelligence Pathology Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Artificial Intelligence Pathology Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Artificial Intelligence Pathology Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Artificial Intelligence Pathology Diagnosis Market Share by Region (2019-2024)
Table 10. Global Artificial Intelligence Pathology Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Artificial Intelligence Pathology Diagnosis Market Share by Region (2025-2030)
Table 12. Artificial Intelligence Pathology Diagnosis Market Trends
Table 13. Artificial Intelligence Pathology Diagnosis Market Drivers
Table 14. Artificial Intelligence Pathology Diagnosis Market Challenges
Table 15. Artificial Intelligence Pathology Diagnosis Market Restraints
Table 16. Global Artificial Intelligence Pathology Diagnosis Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Artificial Intelligence Pathology Diagnosis Market Share by Players (2019-2024)
Table 18. Global Top Artificial Intelligence Pathology Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Pathology Diagnosis as of 2023)
Table 19. Ranking of Global Top Artificial Intelligence Pathology Diagnosis Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Artificial Intelligence Pathology Diagnosis Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Artificial Intelligence Pathology Diagnosis Product Solution and Service
Table 23. Date of Enter into Artificial Intelligence Pathology Diagnosis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Artificial Intelligence Pathology Diagnosis Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Artificial Intelligence Pathology Diagnosis Revenue Market Share by Type (2019-2024)
Table 27. Global Artificial Intelligence Pathology Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Artificial Intelligence Pathology Diagnosis Revenue Market Share by Type (2025-2030)
Table 29. Global Artificial Intelligence Pathology Diagnosis Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Artificial Intelligence Pathology Diagnosis Revenue Market Share by Application (2019-2024)
Table 31. Global Artificial Intelligence Pathology Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Artificial Intelligence Pathology Diagnosis Revenue Market Share by Application (2025-2030)
Table 33. North America Artificial Intelligence Pathology Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Artificial Intelligence Pathology Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Artificial Intelligence Pathology Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Artificial Intelligence Pathology Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Artificial Intelligence Pathology Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Artificial Intelligence Pathology Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Artificial Intelligence Pathology Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Artificial Intelligence Pathology Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Artificial Intelligence Pathology Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 48. Aiforia Company Detail
Table 49. Aiforia Business Overview
Table 50. Aiforia Artificial Intelligence Pathology Diagnosis Product
Table 51. Aiforia Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 52. Aiforia Recent Development
Table 53. AIRA Matrix Company Detail
Table 54. AIRA Matrix Business Overview
Table 55. AIRA Matrix Artificial Intelligence Pathology Diagnosis Product
Table 56. AIRA Matrix Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 57. AIRA Matrix Recent Development
Table 58. Deep Bio Company Detail
Table 59. Deep Bio Business Overview
Table 60. Deep Bio Artificial Intelligence Pathology Diagnosis Product
Table 61. Deep Bio Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 62. Deep Bio Recent Development
Table 63. DoMore Diagnostics Company Detail
Table 64. DoMore Diagnostics Business Overview
Table 65. DoMore Diagnostics Artificial Intelligence Pathology Diagnosis Product
Table 66. DoMore Diagnostics Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 67. DoMore Diagnostics Recent Development
Table 68. Indica Labs Company Detail
Table 69. Indica Labs Business Overview
Table 70. Indica Labs Artificial Intelligence Pathology Diagnosis Product
Table 71. Indica Labs Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 72. Indica Labs Recent Development
Table 73. Mindpeak Company Detail
Table 74. Mindpeak Business Overview
Table 75. Mindpeak Artificial Intelligence Pathology Diagnosis Product
Table 76. Mindpeak Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 77. Mindpeak Recent Development
Table 78. Paige AI Company Detail
Table 79. Paige AI Business Overview
Table 80. Paige AI Artificial Intelligence Pathology Diagnosis Product
Table 81. Paige AI Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 82. Paige AI Recent Development
Table 83. Path AI Company Detail
Table 84. Path AI Business Overview
Table 85. Path AI Artificial Intelligence Pathology Diagnosis Product
Table 86. Path AI Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 87. Path AI Recent Development
Table 88. Tempus Company Detail
Table 89. Tempus Business Overview
Table 90. Tempus Artificial Intelligence Pathology Diagnosis Product
Table 91. Tempus Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 92. Tempus Recent Development
Table 93. Verily Company Detail
Table 94. Verily Business Overview
Table 95. Verily Artificial Intelligence Pathology Diagnosis Product
Table 96. Verily Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 97. Verily Recent Development
Table 98. Aignostics GmbH Company Detail
Table 99. Aignostics GmbH Business Overview
Table 100. Aignostics GmbH Artificial Intelligence Pathology Diagnosis Product
Table 101. Aignostics GmbH Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 102. Aignostics GmbH Recent Development
Table 103. Gestalt Diagnostics Company Detail
Table 104. Gestalt Diagnostics Business Overview
Table 105. Gestalt Diagnostics Artificial Intelligence Pathology Diagnosis Product
Table 106. Gestalt Diagnostics Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 107. Gestalt Diagnostics Recent Development
Table 108. Primma Company Detail
Table 109. Primma Business Overview
Table 110. Primma Artificial Intelligence Pathology Diagnosis Product
Table 111. Primma Revenue in Artificial Intelligence Pathology Diagnosis Business (2019-2024) & (US$ Million)
Table 112. Primma Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Intelligence Pathology Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Artificial Intelligence Pathology Diagnosis Market Share by Type: 2023 VS 2030
Figure 3. Histopathology Features
Figure 4. Cytopathology Features
Figure 5. Immunohistochemical Pathology Features
Figure 6. Molecular Pathology Features
Figure 7. Global Artificial Intelligence Pathology Diagnosis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Artificial Intelligence Pathology Diagnosis Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Diagnostic Laboratory Case Studies
Figure 11. Training and Education Case Studies
Figure 12. Artificial Intelligence Pathology Diagnosis Report Years Considered
Figure 13. Global Artificial Intelligence Pathology Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Artificial Intelligence Pathology Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Artificial Intelligence Pathology Diagnosis Market Share by Region: 2023 VS 2030
Figure 16. Global Artificial Intelligence Pathology Diagnosis Market Share by Players in 2023
Figure 17. Global Top Artificial Intelligence Pathology Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Pathology Diagnosis as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Artificial Intelligence Pathology Diagnosis Revenue in 2023
Figure 19. North America Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Artificial Intelligence Pathology Diagnosis Market Share by Country (2019-2030)
Figure 21. United States Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Artificial Intelligence Pathology Diagnosis Market Share by Country (2019-2030)
Figure 25. Germany Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Share by Region (2019-2030)
Figure 33. China Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Artificial Intelligence Pathology Diagnosis Market Share by Country (2019-2030)
Figure 41. Mexico Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Share by Country (2019-2030)
Figure 45. Turkey Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Artificial Intelligence Pathology Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Aiforia Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 48. AIRA Matrix Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 49. Deep Bio Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 50. DoMore Diagnostics Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 51. Indica Labs Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 52. Mindpeak Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 53. Paige AI Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 54. Path AI Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 55. Tempus Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 56. Verily Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 57. Aignostics GmbH Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 58. Gestalt Diagnostics Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 59. Primma Revenue Growth Rate in Artificial Intelligence Pathology Diagnosis Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
